Testing The Limits? FDA Drugs Of Abuse Guidance Draws Mixed Reaction
This article was originally published in The Gray Sheet
Executive Summary
On-site testing manufacturers once again are questioning FDA's regulatory authority regarding on-site drugs of abuse tests intended for non-medical purposes
You may also be interested in...
Drug Abuse Test Manufacturers May Benefit From Revised Federal Standards
The House Energy & Commerce Committee will explore and promote alternative technologies for drugs-of-abuse testing in the workplace, according to Alan Slobodin, deputy chief counsel for oversight
Drug Abuse Test Manufacturers May Benefit From Revised Federal Standards
The House Energy & Commerce Committee will explore and promote alternative technologies for drugs-of-abuse testing in the workplace, according to Alan Slobodin, deputy chief counsel for oversight
Warning Letter To Alcohol Test Manufacturer Cites Purchasing Control Lapses
FDA's warning letter to WNCK spotlights FDA oversight of non-medical substance abuse tests